Skip to main content
Screener/Healthcare/Biotechnology

REPL — Replimune Group, Inc.

NASDAQ
$11.29+5.96 (+110.07%)
Small CapUnder $20Healthcare
$1.50
$12.50
$9.43
$12.50
EPS (TTM)$-3.58
P/E Ratio-0.75
Dividend Yield—
Market Cap$878.1M
Volume30.36M
Prev Close$5.41
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '26$0-$70.9M$-0.77——
Q2 '26$0-$83.1M$-0.90——
Q1 '26$0-$86.7M$-0.95——
Q4 '25$0-$74.1M$-0.96——
Q3 '25$0-$66.3M$-0.79——
Q2 '25$0-$53.1M$-0.68——
Q1 '25$0-$53.8M$-0.78——
Q4 '24$0-$55.1M$-0.90——
Get Your Daily Market Recap